Podcasts Health & Fitness Medicine NEJM Interviews NEJM Interview: Dr. Jerry Avorn on a new estimate of the cost of bringing a drug to market.

NEJM Interview: Dr. Jerry Avorn on a new estimate of the cost of bringing a drug to market.

Published: May 13, 2015, 4:01 p.m.

b'Jerry Avorn is a professor of medicine at Harvard Medical School and chief of the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women\\u2019s Hospital. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. J. Avorn. The $2.6 Billion Pill - Methodologic and Policy Considerations. N Engl J Med 2015;372:1877-9.'